Institut De Recherches Cliniques de Montreal

Patent Applications and Registrations

Patent applications and USPTO patent grants for Institut De Recherches Cliniques de Montreal.The latest application filed is for "methods for preventing or treating mitochondrial permeability transition".

Company Profile

4.10.13

Institut De Recherches Cliniques de Montreal - Montreal CA
Institut de Recherches Cliniques de Montreal - Cornell University
INSTITUT DE RECHERCHES CLINIQUES DE MONTREAL - MONTREAL, OUEBEC CA
Institut de Recherches Cliniques de Montreal - CA CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods For Preventing Or Treating Mitochondrial Permeability Transition App 20200038472 - Szeto; Hazel H. ; et al.	2020-02-06
Aromatic-cationic Peptides And Uses Of Same App 20190330272 - SZETO; Hazel H. ; et al.	2019-10-31
Aromatic-cationic Peptides And Uses Of Same App 20180244721 - SZETO; Hazel H. ; et al.	2018-08-30
Methods For Preventing Or Treating Mitochondrial Permeability Transition App 20150359838 - Szeto; Hazel H. ; et al.	2015-12-17
Methods for preventing or treating mitochondrial permeability transition Grant 8,957,030 - Szeto , et al. February 17, 2	2015-02-17
Aromatic-cationic Peptides And Uses Of Same App 20150005242 - SZETO; Hazel H. ; et al.	2015-01-01
Modulation Of The Sonic Hedgehog Pathway And Uses Thereof App 20140079713 - Charron; Frederic ; et al.	2014-03-20
PCSK9 inhibitors and methods of use thereof Grant 8,673,850 - Seidah , et al. March 18, 2	2014-03-18
Aromatic-cationic Peptides And Uses Of Same App 20130316964 - SZETO; Hazel H. ; et al.	2013-11-28
Gfi1b Modulation And Uses Thereof App 20130149311 - Moroy; Tarik ; et al.	2013-06-13
Methods for preventing or treating mitochondrial permeability transition Grant 8,404,646 - Schiller , et al. March 26, 2	2013-03-26
Nucleoside and nucleotide analogues with quaternary carbon centers and methods of use Grant 8,361,988 - Guindon January 29, 2	2013-01-29
Aromatic-cationic Peptides And Uses Of Same App 20120329730 - Szeto; Hazel H. ; et al.	2012-12-27
Hedgehog pathway modulation and uses thereof for treating, preventing and/or diagnosing cancer Grant 8,241,846 - Charron , et al. August 14, 2	2012-08-14
Methods of reducing a viral infection and kits therefore Grant 8,088,571 - Seidah , et al. January 3, 2	2012-01-03
Nucleotide Analogues With Quaternary Carbon Stereogenic Centers And Methods Of Use App 20110092451 - Guindon; Yvan	2011-04-21
Chimeric Pcsk9 Proteins, Cells Comprising Same, And Assays Using Same App 20110003315 - Seidah; Nabil G. ; et al.	2011-01-06
Nucleoside and Nucleotide Analogues with Quaternary Carbon Centers and Methods of Use App 20100093737 - Guindon; Yvan	2010-04-15
Screening Proteinase Modulators Using A Chimeric Protein And Ski-i Proprotein Convertase Substrates And Inhibitors App 20090130691 - Seidah; Nabil ; et al.	2009-05-21
Nucleic acids encoding mutant human CD80 and compositions comprising the same Grant 7,446,189 - Weiner , et al. November 4, 2	2008-11-04
Mammalian Subtilisin/kexin isozyme SKI-1: a proprotein convertase with a unique cleavage specificity Grant 7,211,424 - Seidah , et al. May 1, 2	2007-05-01
Nur-RE a response element which binds nur nuclear receptors and method of use therefor Grant 6,852,538 - Drouin , et al. February 8, 2	2005-02-08
Method and apparatus for estimating systolic and mean pulmonary artery pressures of a patient Grant 6,368,283 - Xu , et al. April 9, 2	2002-04-09

Company Registrations

CAGE Code	L5845	INSTITUT DE RECHERCHES CLINIQUES DE MONTREAL I.R.C.M.
S.A.M. Registration	L5845 [201373169]	INSTITUT DE RECHERCHES CLINIQUES DE MONTREAL I.R.C.M.

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.